[HTML][HTML] Real-world clinical outcomes of molnupiravir for the treatment of mild to moderate COVID-19 in adult patients during the dominance of the Omicron variant: a …
C Huang, TL Lu, L Lin - Antibiotics, 2023 - mdpi.com
Introduction: The therapeutic impact of molnupiravir in the Omicron variant phase is
unknown. The goal of the current meta-analysis was to compare the real-world clinical …
unknown. The goal of the current meta-analysis was to compare the real-world clinical …
Real-World Clinical Outcomes of Molnupiravir for the Treatment of Mild to Moderate COVID-19 in Adult Patients during the Dominance of the Omicron Variant: A Meta …
C Huang, TL Lu, L Lin - Antibiotics (Basel, Switzerland), 2023 - europepmc.org
Methods To be included, studies had to directly compare the clinical effectiveness of
molnupiravir in treating adult COVID-19 patients to that of a placebo. Studies were included …
molnupiravir in treating adult COVID-19 patients to that of a placebo. Studies were included …
Real-World Clinical Outcomes of Molnupiravir for the Treatment of Mild to Moderate COVID-19 in Adult Patients during the Dominance of the Omicron Variant: A Meta …
C Huang, TL Lu, L Lin - Antibiotics (Basel, Switzerland), 2023 - pubmed.ncbi.nlm.nih.gov
Introduction The therapeutic impact of molnupiravir in the Omicron variant phase is
unknown. The goal of the current meta-analysis was to compare the real-world clinical …
unknown. The goal of the current meta-analysis was to compare the real-world clinical …
[HTML][HTML] Real-World Clinical Outcomes of Molnupiravir for the Treatment of Mild to Moderate COVID-19 in Adult Patients during the Dominance of the Omicron Variant …
C Huang, TL Lu, L Lin - Antibiotics, 2023 - ncbi.nlm.nih.gov
Introduction: The therapeutic impact of molnupiravir in the Omicron variant phase is
unknown. The goal of the current meta-analysis was to compare the real-world clinical …
unknown. The goal of the current meta-analysis was to compare the real-world clinical …
Real-World Clinical Outcomes of Molnupiravir for the Treatment of Mild to Moderate COVID-19 in Adult Patients during the Dominance of the Omicron Variant: A Meta …
C Huang, TL Lu, L Lin - Antibiotics (2079-6382), 2023 - search.ebscohost.com
Introduction: The therapeutic impact of molnupiravir in the Omicron variant phase is
unknown. The goal of the current meta-analysis was to compare the real-world clinical …
unknown. The goal of the current meta-analysis was to compare the real-world clinical …
Real-World Clinical Outcomes of Molnupiravir for the Treatment of Mild to Moderate COVID-19 in Adult Patients during the Dominance of the Omicron Variant: A Meta …
C Huang, TL Lu, L Lin - Antibiotics, 2023 - search.proquest.com
Introduction: The therapeutic impact of molnupiravir in the Omicron variant phase is
unknown. The goal of the current meta-analysis was to compare the real-world clinical …
unknown. The goal of the current meta-analysis was to compare the real-world clinical …
Real-world clinical outcomes of molnupiravir for the treatment of mild to moderate COVID-19 in adult patients during the dominance of the omicron variant: a meta …
C Huang, TL Lu, L Lin - 2023 - cabidigitallibrary.org
Introduction: The therapeutic impact of molnupiravir in the Omicron variant phase is
unknown. The goal of the current meta-analysis was to compare the real-world clinical …
unknown. The goal of the current meta-analysis was to compare the real-world clinical …
Real-World Clinical Outcomes of Molnupiravir for the Treatment of Mild to Moderate COVID-19 in Adult Patients during the Dominance of the Omicron Variant: A Meta …
C Huang, TL Lu, L Lin - Antibiotics (Basel, Switzerland), 2023 - europepmc.org
Methods To be included, studies had to directly compare the clinical effectiveness of
molnupiravir in treating adult COVID-19 patients to that of a placebo. Studies were included …
molnupiravir in treating adult COVID-19 patients to that of a placebo. Studies were included …